Communications Medicine (Jul 2022)

Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report

  • Marie-Anne Meier,
  • Sandro Nuciforo,
  • Mairene Coto-Llerena,
  • John Gallon,
  • Matthias S. Matter,
  • Caner Ercan,
  • Jürg Vosbeck,
  • Luigi M. Terracciano,
  • Savas D. Soysal,
  • Daniel Boll,
  • Otto Kollmar,
  • Raphaël Delaloye,
  • Salvatore Piscuoglio,
  • Markus H. Heim

DOI
https://doi.org/10.1038/s43856-022-00150-3
Journal volume & issue
Vol. 2, no. 1
pp. 1 – 8

Abstract

Read online

Meier, Nuciforo, Coto-Llerena et al. report a rare case of a patient with hepatocellular carcinoma with neuroendocrine differentiation. The authors establish organoids that recapitulate the genetic features of the patient’s tumor and are used for ex vivo drug testing to guide therapy selection in the patient.